Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Turn Insight Into Action! Attend Learning Labs at AAA 2026
Ready to take your professional development to the next level? At AAA 2026, Learning Labs are your chance to go beyond lectures and dive into…
Your Support Makes the Difference—Let’s Finish the Year Strong
As we wrap up the year, I want to thank you for your generosity supporting the AAA Foundation’s work. The enclosed report highlights what you…
Audiology Faces New Challenges Under Draft Federal Loan Rule: What Comes Next
Member Action Needed Soon! The U.S. Department of Education’s Advisory Committee has reached consensus on proposed regulations implementing the higher education provisions of the One…


